Global pharmaceutical company Sanofi is partnering with Healx, a U.K.-based clinical-stage biotech specializing in rare diseases, to use its artificial intelligence to identify novel rare disease ...
Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all detectable traces of a brain cancer.
To address environmental concerns surrounding bioprocessing, companies must be proactive. In a recent preprint, Andrew Sinclair, president and founder of U.K.-based Biopharm Services, which is a ...